Sign in

NCT04047264Recruiting

Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

Source: ClinicalTrials.gov · Last updated 18 Aug 2026

Brief summary (registry, in English)

This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intra- and post-operative microdialysis during neurosurgery for central nervous system malignancies. A biomarker is a measurable indicator of the severity or presence of disease state. Information collected in this study may help doctors develop new strategies to better diagnose, monitor, and treat brain tumors.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
29 Jul 2019
Start date
1 Jan 2020
Primary completion date
1 Sept 2027
Lead sponsor
Mayo Clinic
Diseases
Glioblastoma
NCT number
NCT04047264

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Jan 2020 to the primary completion date, 1 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who are not appropriate candidates for surgery due to current or past medical history or uncontrolled concurrent illness

Other

  • Vulnerable populations: pregnant women, prisoners or the mentally handicapped

Who the study is looking for

  • Age \>= 18 years
  • Diagnosis of the following, based on clinical and radiographic evidence:
    • Any glioma
    • Metastatic brain tumor of any primary origin
    • Epileptic focus requiring surgical resection
  • Planned neurosurgical procedure for purposes of biopsy or resection of suspected or previously diagnosed brain tumor (primary or metastatic) or epileptic focus as part of routine clinical care
  • Willing to undergo neurosurgical resection or biopsy at Mayo Clinic \[Rochester, Minnesota (MN)\]
  • For patients with gliomas recruited for post-operative microdialysis, willingness to stay in the hospital through post-operative day (POD) 3-5 (timing per physician and patient's shared decision making)
  • Ability to understand and the willingness to sign a written informed consent document
  • Enrollment into the Biobank study (IRB#12-003458)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic in Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.